George Mason University Schar School of Policy and Government Biodefense, MPP and MPA Programs will co-host a no-fee webinar event, "Policy vs. Pandemics: Polarization and Public Health Emergency Preparedness" on
Notice from organizers 17 March 2020 After much deliberation and consideration of the Decennial participants’ substantial role in addressing COVID-19 globally, the Society for Healthcare Epidemiology of America’s Board of
Amidst the flood of information about the COVID-19 pandemic, one of the greatest risks is missing key intelligence that can protect health and save lives. This town hall-style webinar, co-hosted
Due to ongoing concerns over COVID-19 this conference is now available with remote access only SMi’s 22nd Annual Superbugs & Superdrugs 2020 Conference will be held 30-31 March 2020. A
If your small business has strong experience with scientific data processing and outreach, consider sending a contract proposal to establish an Influenza Data Processing and Communication Center (iDPCC). This solicitation
COVID-19 has had a profound impact on supply chains for many different critical products worldwide. The pandemic has created major changes in freight flows and has challenged the ability to
Research Area 001: Development of Radiation/Nuclear Medical Countermeasures (MCMs) HHS-NIH-NIAID-BAA2020-1 This research topic call for proposals is part of the 2020 NIAID Omnibus Broad Agency Announcement. It supports the development
HHS-NIH-NIAID-BAA2020-1 Research Area 004: Development of Therapeutic Products for Biodefense, Anti-Microbial Resistant (AMR) Infections, and Emerging Infectious Diseases Supports development of promising new therapeutics to address infections caused by NIAID Category
HHS-NIH-NIAID-BAA2020-1 Research Area 003: Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases Supports development of vaccines 1) to address antibiotic resistant gram-negative bacteria focusing on but not
